Haemorrhagic and haematological disorders of fetus and newborn

No definition available.

Endpoint definition

↥

Name	P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
Long name	Haemorrhagic and haematological disorders of fetus and newborn
Include	P16_FETAL_BLOOD_LOSS, P16_UMBIL_HAEMORRHAGE_NEWBO, P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO, P16_HAEMORRHAGIC_DISEA_FETUS_NEWBO, P16_OTH_NEONTAL_HAEMORRHAGES, P16_HAEMOLYTIC_DISEA_FETUS_NEWBO, P16_HYDROPS_FETALIS_HAEMOLYTIC_DISEA, P16_KERNICTERUS, P16_NEONTAL_JAUND_OTH_EXCESSI_HAEMOLYS, P16_NEONTAL_JAUND_OTH_UNSP_CAUSES, P16_DISSEM_INTRAVA_COAGU_FETUS_NEWBO, P16_OTH_PERINA_HAEMATOL_DISORD
Level in the ICD-hierarchy	2
First defined in version	DF4
Latin name	Morbositates haemorrhagicae et haematologicae fetus et neonati

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	184	94	90
Unadjusted prevalence (%)	0.08	0.08	0.10
Mean age at first event (years)	0.72	0.44	1.00
Case fatality at 5-years (%)	0.00	0.00	0.00

Longitudinal metrics

	All	Female	Male
Median nb. of events per indiv.	1.0	1.0	1.0
Recurrence at 6 months (%)	9.78	9.57	10.00

Survival analyses between endpoints

↥

Plot

before Haemorrhagic and haematological disorders of fetus and newborn
after Haemorrhagic and haematological disorders of fetus and newborn

Loading survival analyses plot…

Table

Loading survival analyses table…

Drugs most likely to be purchased after Haemorrhagic and haematological disorders of fetus and newborn

↥